These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3891197)

  • 21. Alterations in pentobarbital and meperidine pharmacokinetics induced by bile duct ligation in the rat.
    Knodell RG; Brooks DA; Allen RC; Kyner WT
    J Pharmacol Exp Ther; 1980 Dec; 215(3):619-25. PubMed ID: 7441521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prediction of human clearance from hepatic microsomal metabolism data.
    Obach RS
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):36-44. PubMed ID: 11727321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interpretation of metabolic function of the lung. Influence of perfusion, kinetics, and injury.
    Pitt BR; Lister G
    Clin Chest Med; 1989 Mar; 10(1):1-12. PubMed ID: 2650960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uptake and intracellular binding of lipophilic amine drugs by isolated rat hepatocytes and implications for prediction of in vivo metabolic clearance.
    Hallifax D; Houston JB
    Drug Metab Dispos; 2006 Nov; 34(11):1829-36. PubMed ID: 16882765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of prolonged desmethylimipramine administration on the pulmonary clearance of 5-hydroxytryptamine and beta-phenylethylamine in rats.
    Minchin RF; Barber HE; Ilett KF
    Drug Metab Dispos; 1982; 10(4):356-60. PubMed ID: 6126334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on the induction by extracts from airborne particulates of benzo(a)pyrene hydroxylase and the binding of benzo(a)pyrene to DNA in the rat lung in vivo after pertracheal administration (author's transl)].
    Dehnen W; Verbücheln J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1981 Dec; 174(3):260-73. PubMed ID: 6277103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the lung in total body clearance of circulating drugs.
    Roth RA; Wiersma DA
    Clin Pharmacokinet; 1979; 4(5):355-67. PubMed ID: 41661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new model-independent physiological approach to study hepatic drug clearance and its applications.
    Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of bleomycin-induced fibrosis on pulmonary metabolism of selected xenobiotics.
    Pillai UA; Schlenk D; Frith C; Ferguson PW
    J La State Med Soc; 1994 Jun; 146(6):260-7. PubMed ID: 7520052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired elimination of propranolol due to right heart failure: drug clearance in the isolated liver and its relationship to intrinsic metabolic capacity.
    Ng CY; Ghabrial H; Morgan DJ; Ching MS; Smallwood RA; Angus PW
    Drug Metab Dispos; 2000 Oct; 28(10):1217-21. PubMed ID: 10997943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of red blood cells, serum albumin, and serum lipoproteins on the clearance of benzo[alpha]pyrene by isolated livers of 3-methylcholanthrene-treated rats.
    Wiersma DA; Stemmer PM; Roth RA
    Biochem Pharmacol; 1984 Nov; 33(21):3433-8. PubMed ID: 6497903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diseased lung and drugs.
    Camus P; Jeannin L
    Arch Toxicol Suppl; 1984; 7():66-87. PubMed ID: 6596027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic circulation and drug disposition in cirrhosis.
    Shand DG
    Gastroenterology; 1979 Jul; 77(1):185-6. PubMed ID: 447017
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of the lung in accumulation and metabolism of xenobiotic compounds--implications for chemically induced toxicity.
    Foth H
    Crit Rev Toxicol; 1995; 25(2):165-205. PubMed ID: 7612175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intratracheally administered lindane on aldrin and benzo(a)pyrene contents in lungs of rats.
    Khan MA; Matin MA; Beg MU
    Toxicol Lett; 1993 Jul; 69(1):63-7. PubMed ID: 7689255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of lungs to total body clearance: linear and nonlinear effects.
    Collins JM; Dedrick RL
    J Pharm Sci; 1982 Jan; 71(1):66-70. PubMed ID: 7057383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetic aspects of drug disposition in the lungs.
    Upton RN; Doolette DJ
    Clin Exp Pharmacol Physiol; 1999; 26(5-6):381-91. PubMed ID: 10386226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of nanomaterials in vivo: blood circulation and organ clearance.
    Wang B; He X; Zhang Z; Zhao Y; Feng W
    Acc Chem Res; 2013 Mar; 46(3):761-9. PubMed ID: 23964655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extrahepatic metabolism of drugs in humans.
    Krishna DR; Klotz U
    Clin Pharmacokinet; 1994 Feb; 26(2):144-60. PubMed ID: 8162658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.